Literature DB >> 25920804

Clinical presentation and pharmacotherapy response in social anxiety disorder: The effect of etiological beliefs.

Jonah N Cohen1, Carrie M Potter1, Deborah A G Drabick1, Carlos Blanco2, Franklin R Schneier2, Michael R Liebowitz3, Richard G Heimberg4.   

Abstract

Therapies for social anxiety disorder (SAD) leave many patients symptomatic at the end of treatment and little is known about predictors of treatment response. This study investigated the predictive relationship of patients' etiological attributions to initial clinical features and response to pharmacotherapy. One hundred thirty-seven individuals seeking treatment for SAD received 12 weeks of open treatment with paroxetine. Participants completed the Attributions for the Etiology of Social Anxiety Scale at baseline in addition to measures of social anxiety and depression at baseline and over the course of treatment. A latent class analysis suggested four profiles of etiological beliefs about one's SAD that may be characterized as: Familial Factors, Need to be Liked, Bad Social Experiences, and Diffuse Beliefs. Patients in the more psychosocially-driven classes, Need to be Liked and Bad Social Experiences, had the most severe social anxiety and depression at baseline. Patients in the Familial Factors class, who attributed their SAD to genetic, biological, and early life experiences, had the most rapid response to paroxetine.These results highlight the effect of biological and genetically-oriented etiological beliefs on pharmacological intervention, have implications for person-specific treatment selection, and identify potential points of intervention to augment treatment response.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Latent class analysis; Paroxetine; Personalized medicine; Social anxiety disorder; Social phobia; Treatment-matching

Mesh:

Substances:

Year:  2015        PMID: 25920804      PMCID: PMC4416216          DOI: 10.1016/j.psychres.2015.04.014

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  45 in total

1.  Childhood maltreatment and social anxiety disorder: implications for symptom severity and response to pharmacotherapy.

Authors:  Laura C Bruce; Richard G Heimberg; Carlos Blanco; Franklin R Schneier; Michael R Liebowitz
Journal:  Depress Anxiety       Date:  2011-11-07       Impact factor: 6.505

2.  Clients' expectancies and their relationship to pretreatment symptomatology and outcome of cognitive-behavioral group treatment for social phobia.

Authors:  S A Safren; R G Heimberg; H R Juster
Journal:  J Consult Clin Psychol       Date:  1997-08

3.  Paroxetine in social phobia/social anxiety disorder. Randomised, double-blind, placebo-controlled study. Paroxetine Study Group.

Authors:  D Baldwin; J Bobes; D J Stein; I Scharwächter; M Faure
Journal:  Br J Psychiatry       Date:  1999-08       Impact factor: 9.319

4.  Social phobia.

Authors:  M R Liebowitz
Journal:  Mod Probl Pharmacopsychiatry       Date:  1987

5.  The etiology and maintenance of severe animal phobias.

Authors:  R J McNally; G S Steketee
Journal:  Behav Res Ther       Date:  1985

6.  Integrating person-centered and variable-centered analyses: growth mixture modeling with latent trajectory classes.

Authors:  B Muthén; L K Muthén
Journal:  Alcohol Clin Exp Res       Date:  2000-06       Impact factor: 3.455

7.  The impact of anxiety disorders on educational achievement.

Authors:  Michael Van Ameringen; Catherine Mancini; Peter Farvolden
Journal:  J Anxiety Disord       Date:  2003

8.  Parenting: a genetic-epidemiologic perspective.

Authors:  K S Kendler
Journal:  Am J Psychiatry       Date:  1996-01       Impact factor: 18.112

9.  Patient expectations in internet-based self-help for social anxiety.

Authors:  Johanna Boettcher; Babette Renneberg; Thomas Berger
Journal:  Cogn Behav Ther       Date:  2013-05-22

10.  Economic costs of social phobia: a population-based study.

Authors:  C Acarturk; Filip Smit; R de Graaf; A van Straten; M Ten Have; P Cuijpers
Journal:  J Affect Disord       Date:  2008-11-13       Impact factor: 4.839

View more
  1 in total

1.  Change in posttraumatic stress disorder-related thoughts during treatment: Do thoughts drive change when pills are involved?

Authors:  Sheila A M Rauch; H Myra Kim; Margaret R Venners; Katherine E Porter; Sonya B Norman; Naomi M Simon; Barbara O Rothbaum; Peter W Tuerk; Ronald E Acierno; Eric Bui; Corey Powell; Erin R Smith; Elizabeth Goetter; Lauren B McSweeney
Journal:  J Trauma Stress       Date:  2021-12-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.